Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

T cell monitoring of chemotherapy in experimental rat tuberculosis.

Foo DG, Tay HC, Siew JY, Singhal A, Camacho L, Bifani P, Dartois V, Hervé M.

Antimicrob Agents Chemother. 2011 Aug;55(8):3677-83. doi: 10.1128/AAC.00136-11. Epub 2011 May 31.

2.

Sustained high levels of interleukin-6 contribute to the pathogenesis of enterovirus 71 in a neonate mouse model.

Khong WX, Foo DG, Trasti SL, Tan EL, Alonso S.

J Virol. 2011 Apr;85(7):3067-76. doi: 10.1128/JVI.01779-10. Epub 2011 Jan 12.

3.

Identification of human CD4 T-cell epitopes on the VP1 capsid protein of enterovirus 71.

Foo DG, Macary PA, Alonso S, Poh CL.

Viral Immunol. 2008 Jun;21(2):215-24. doi: 10.1089/vim.2007.0089.

PMID:
18419256
4.

Identification of immunodominant VP1 linear epitope of enterovirus 71 (EV71) using synthetic peptides for detecting human anti-EV71 IgG antibodies in Western blots.

Foo DG, Ang RX, Alonso S, Chow VT, Quak SH, Poh CL.

Clin Microbiol Infect. 2008 Mar;14(3):286-8. Epub 2007 Dec 8.

5.

Highly attenuated Bordetella pertussis strain BPZE1 as a potential live vehicle for delivery of heterologous vaccine candidates.

Ho SY, Chua SQ, Foo DG, Locht C, Chow VT, Poh CL, Alonso S.

Infect Immun. 2008 Jan;76(1):111-9. Epub 2007 Oct 22.

6.

Passive protection against lethal enterovirus 71 infection in newborn mice by neutralizing antibodies elicited by a synthetic peptide.

Foo DG, Alonso S, Chow VT, Poh CL.

Microbes Infect. 2007 Sep;9(11):1299-306. Epub 2007 Jun 10.

PMID:
17890123
7.

Identification of neutralizing linear epitopes from the VP1 capsid protein of Enterovirus 71 using synthetic peptides.

Foo DG, Alonso S, Phoon MC, Ramachandran NP, Chow VT, Poh CL.

Virus Res. 2007 Apr;125(1):61-8. Epub 2007 Jan 12.

PMID:
17222936

Supplemental Content

Support Center